Dysplasia in ulcerative colitis: Still a challenge

Mauro Frego, Marco Scarpa, Alessio Bridda, Norberto Lorenzo, Maurizio Iacobone, Giorgio Bianchera

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

As duration of inflammatory bowel disease (IBD), in particular ulcerative colitis (UC), is a major risk factor for the development of colorectal cancer (CRC), it is rational to propose a screening colonoscopy when the risk starts to increase, i.e. after 8-10 years from the onset of disease. If low-grade dysplasia is detected, the 9-fold increased risk of developing CRC reported in the most recent meta-analysis could reasonably be viewed as justification for colectomy even if some follow-up studies have shown a lower rate of CRC. A reasonable compromise could be to continue surveillance with extensive biopsy sampling at shorter (perhaps 3-6 month) intervals. If high grade dysplasia is present, the decision is easier, because the risk of concomitant CRC may be as high as one third, assuming that the biopsies were indeed obtained from flat mucosa and not from an adenoma. Total proctocolectomy with ileal pouch anal anastomosis (IPAA) has become the most commonly performed procedure for patients with ulcerative colitis requiring elective surgery for dysplasia. Nevertheless, a recent systematic review alerted that the risk of dysplasia in anal transition zone and rectal cuff in patients undergone to restorative proctocolectomy was remarkable, mainly in patients operated on for dysplasia or colorectal cancer.

Original languageEnglish
Pages (from-to)5-10
Number of pages6
JournalAnnali Italiani di Chirurgia
Volume82
Issue number1
Publication statusPublished - Feb 2011

Fingerprint

Ulcerative Colitis
Colorectal Neoplasms
Restorative Proctocolectomy
Biopsy
Colonic Pouches
Colectomy
Colonoscopy
Inflammatory Bowel Diseases
Adenoma
Meta-Analysis
Mucous Membrane

Keywords

  • Colonoscopy surveillance
  • Colorectal cancer
  • Dysplasia
  • Ileal-pouch anastomosis
  • Restorative proctolcolectomy
  • Ulcerative colitis

ASJC Scopus subject areas

  • Surgery

Cite this

Frego, M., Scarpa, M., Bridda, A., Lorenzo, N., Iacobone, M., & Bianchera, G. (2011). Dysplasia in ulcerative colitis: Still a challenge. Annali Italiani di Chirurgia, 82(1), 5-10.

Dysplasia in ulcerative colitis : Still a challenge. / Frego, Mauro; Scarpa, Marco; Bridda, Alessio; Lorenzo, Norberto; Iacobone, Maurizio; Bianchera, Giorgio.

In: Annali Italiani di Chirurgia, Vol. 82, No. 1, 02.2011, p. 5-10.

Research output: Contribution to journalArticle

Frego, M, Scarpa, M, Bridda, A, Lorenzo, N, Iacobone, M & Bianchera, G 2011, 'Dysplasia in ulcerative colitis: Still a challenge', Annali Italiani di Chirurgia, vol. 82, no. 1, pp. 5-10.
Frego M, Scarpa M, Bridda A, Lorenzo N, Iacobone M, Bianchera G. Dysplasia in ulcerative colitis: Still a challenge. Annali Italiani di Chirurgia. 2011 Feb;82(1):5-10.
Frego, Mauro ; Scarpa, Marco ; Bridda, Alessio ; Lorenzo, Norberto ; Iacobone, Maurizio ; Bianchera, Giorgio. / Dysplasia in ulcerative colitis : Still a challenge. In: Annali Italiani di Chirurgia. 2011 ; Vol. 82, No. 1. pp. 5-10.
@article{049514440b394fe6879b1bac4df7e51e,
title = "Dysplasia in ulcerative colitis: Still a challenge",
abstract = "As duration of inflammatory bowel disease (IBD), in particular ulcerative colitis (UC), is a major risk factor for the development of colorectal cancer (CRC), it is rational to propose a screening colonoscopy when the risk starts to increase, i.e. after 8-10 years from the onset of disease. If low-grade dysplasia is detected, the 9-fold increased risk of developing CRC reported in the most recent meta-analysis could reasonably be viewed as justification for colectomy even if some follow-up studies have shown a lower rate of CRC. A reasonable compromise could be to continue surveillance with extensive biopsy sampling at shorter (perhaps 3-6 month) intervals. If high grade dysplasia is present, the decision is easier, because the risk of concomitant CRC may be as high as one third, assuming that the biopsies were indeed obtained from flat mucosa and not from an adenoma. Total proctocolectomy with ileal pouch anal anastomosis (IPAA) has become the most commonly performed procedure for patients with ulcerative colitis requiring elective surgery for dysplasia. Nevertheless, a recent systematic review alerted that the risk of dysplasia in anal transition zone and rectal cuff in patients undergone to restorative proctocolectomy was remarkable, mainly in patients operated on for dysplasia or colorectal cancer.",
keywords = "Colonoscopy surveillance, Colorectal cancer, Dysplasia, Ileal-pouch anastomosis, Restorative proctolcolectomy, Ulcerative colitis",
author = "Mauro Frego and Marco Scarpa and Alessio Bridda and Norberto Lorenzo and Maurizio Iacobone and Giorgio Bianchera",
year = "2011",
month = "2",
language = "English",
volume = "82",
pages = "5--10",
journal = "Annali Italiani di Chirurgia",
issn = "0003-469X",
publisher = "Edizioni Luigi Pozzi S.r.l.",
number = "1",

}

TY - JOUR

T1 - Dysplasia in ulcerative colitis

T2 - Still a challenge

AU - Frego, Mauro

AU - Scarpa, Marco

AU - Bridda, Alessio

AU - Lorenzo, Norberto

AU - Iacobone, Maurizio

AU - Bianchera, Giorgio

PY - 2011/2

Y1 - 2011/2

N2 - As duration of inflammatory bowel disease (IBD), in particular ulcerative colitis (UC), is a major risk factor for the development of colorectal cancer (CRC), it is rational to propose a screening colonoscopy when the risk starts to increase, i.e. after 8-10 years from the onset of disease. If low-grade dysplasia is detected, the 9-fold increased risk of developing CRC reported in the most recent meta-analysis could reasonably be viewed as justification for colectomy even if some follow-up studies have shown a lower rate of CRC. A reasonable compromise could be to continue surveillance with extensive biopsy sampling at shorter (perhaps 3-6 month) intervals. If high grade dysplasia is present, the decision is easier, because the risk of concomitant CRC may be as high as one third, assuming that the biopsies were indeed obtained from flat mucosa and not from an adenoma. Total proctocolectomy with ileal pouch anal anastomosis (IPAA) has become the most commonly performed procedure for patients with ulcerative colitis requiring elective surgery for dysplasia. Nevertheless, a recent systematic review alerted that the risk of dysplasia in anal transition zone and rectal cuff in patients undergone to restorative proctocolectomy was remarkable, mainly in patients operated on for dysplasia or colorectal cancer.

AB - As duration of inflammatory bowel disease (IBD), in particular ulcerative colitis (UC), is a major risk factor for the development of colorectal cancer (CRC), it is rational to propose a screening colonoscopy when the risk starts to increase, i.e. after 8-10 years from the onset of disease. If low-grade dysplasia is detected, the 9-fold increased risk of developing CRC reported in the most recent meta-analysis could reasonably be viewed as justification for colectomy even if some follow-up studies have shown a lower rate of CRC. A reasonable compromise could be to continue surveillance with extensive biopsy sampling at shorter (perhaps 3-6 month) intervals. If high grade dysplasia is present, the decision is easier, because the risk of concomitant CRC may be as high as one third, assuming that the biopsies were indeed obtained from flat mucosa and not from an adenoma. Total proctocolectomy with ileal pouch anal anastomosis (IPAA) has become the most commonly performed procedure for patients with ulcerative colitis requiring elective surgery for dysplasia. Nevertheless, a recent systematic review alerted that the risk of dysplasia in anal transition zone and rectal cuff in patients undergone to restorative proctocolectomy was remarkable, mainly in patients operated on for dysplasia or colorectal cancer.

KW - Colonoscopy surveillance

KW - Colorectal cancer

KW - Dysplasia

KW - Ileal-pouch anastomosis

KW - Restorative proctolcolectomy

KW - Ulcerative colitis

UR - http://www.scopus.com/inward/record.url?scp=79955641286&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955641286&partnerID=8YFLogxK

M3 - Article

C2 - 21657149

AN - SCOPUS:79955641286

VL - 82

SP - 5

EP - 10

JO - Annali Italiani di Chirurgia

JF - Annali Italiani di Chirurgia

SN - 0003-469X

IS - 1

ER -